Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

TNM Classification of Malignant Tumours

1987 • 16,209 citations

TNM classification of malignant tumours

1998 • 1,242 citations

Screening for prostate cancer

2013 • 1,131 citations

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

2003 • 1,066 citations

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

2003 • 290 citations

Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer

1994 • 276 citations

Breast cancer screening programmes: the development of a monitoring and evaluation system

1989 • 273 citations

Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma

2003 • 268 citations

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized Trial

2005 • 235 citations

Screening for prostate cancer

2003 • 210 citations

Screening for prostate cancer: estimating the magnitude of overdetection.

1998 • 135 citations

Asymptomatic Incidence and Duration of Prostate Cancer

1998 • 126 citations

Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends

2007 • 121 citations

Impact of PSA Screening on the Incidence of Advanced Stage Prostate Cancer in the United States: A Surveillance Modeling Approach

2008 • 100 citations

Overdiagnosis in Screening: Is the Increase in Breast Cancer Incidence Rates a Cause for Concern ?

2004 • 98 citations

Modelling the Analysis of Breast Cancer Screening Programmes: Sensitivity, Lead Time and Predictive Value in the Florence District Programme (1975–1986)

1991 • 91 citations

Prostate-specific antigen testing accuracy in community practice

2002 • 73 citations

Lead-time in prostate cancer screening (Finland).

2002 • 63 citations

Sensitivity in cancer screening

2007 • 60 citations

Diagnostic Significance of Prostate Specific Antigen and the Development of Mass Screening System for Prostate Cancer

1995 • 58 citations

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

1995 • 55 citations

Does “Clock” Matter in Prostate Cancer?

2006 • 52 citations

Prostate-specific Antigen (PSA), PSA Density and Age-adjusted PSA Reference Values in Screening for Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

1998 • 43 citations

Prostate-Specific Antigen and Digital Rectal Examination in Screening for Prostate Cancer

1994 • 39 citations

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia

2006 • 37 citations

Impact of Additional Sampling in the TRUS-Guided Biopsy for the Diagnosis of Prostate Cancer

2007 • 34 citations

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group

2007 • 33 citations

Asymptomatic Incidence and Duration of Prostate Cancer

1999 • 32 citations

[Detection of cancer, sensitivity of the test and sensitivity of the screening program].

1998 • 16 citations

Clinical Significance of Prostate Specific Antigen for Early Stage Prostate Cancer Detection

1994 • 14 citations

An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice

1998 • 14 citations

Significance of free prostate-specific antigen and gamma-seminoprotein in the screening of prostate cancer

1996 • 10 citations

The value of prostatic specific antigen in prostate cancer screening in the community.

1994 • 4 citations

Modeling the Effect of a Preventive Intervention on the Natural History of Cancer: Application to the Prostate Cancer Prevention Trial

2006 • 1 citations